SCHEMBL4677889

SCHEMBL4677889

CCOC(=O)C(C)(C)Oc1ccc(C(C)(NC)c2cc(-c3ccc(C(F)(F)F)cc3)nn2C)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 3/20 0.40
MRGPRX4 Q96LA9 2/20 0.39
PPARA Q07869 6/20 0.38
PPARG P37231 3/20 0.38
PPARD Q03181 3/20 0.38
GPR119 Q8TDV5 5/20 0.37
NPSR1 Q6W5P4 1/20 0.35
CNR1 P21554 2/20 0.35
MAPT P10636 1/20 0.35
AGER Q15109 1/20 0.34
ABCB11 O95342 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
HTR2A P28223 1/20 0.34
PMP22 Q01453 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4677930 0.93 PPARA (0.39) FBP1MRGPRX4PPARAPPARGPPARD
SCHEMBL4679123 0.92 PPARA (0.45) FBP1PPARAPPARGPPARDGPR119
SCHEMBL4677865 0.91 FBP1 (0.39) FBP1MRGPRX4PPARAPPARGPPARD
SCHEMBL6528502 0.91 PPARA (0.37) FBP1MRGPRX4PPARAPPARGPPARD
SCHEMBL4679444 0.90 FBP1 (0.38) FBP1MRGPRX4PPARAPPARGPPARD
SCHEMBL4683027 0.89 PPARA (0.45) PPARAPPARGPPARD
SCHEMBL4679104 0.88 PPARG (0.43) FBP1PPARAPPARGPPARDGPR119
SCHEMBL4681991 0.87 PPARA (0.43) PPARAPPARGPPARDGPR119CNR1
SCHEMBL4679141 0.84 L3MBTL1 (0.45) FBP1MRGPRX4PPARAPPARGPPARD
SCHEMBL4682140 0.83 PPARA (0.43) FBP1PPARAPPARGPPARDGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513796-B1 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2008-02-13 EP claimed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US claimed
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2005-10-06 US claimed
EP-1513796-B1 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2008-02-13 EP disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2005-10-06 US disclosed
EP-1513796-A2 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2005-03-16 EP disclosed
WO-2004000785-A2 PHENYLOXYALKANONIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators CEL, HPN, LIPA FBP1 393/4885MRGPRX4 619/4885PPARA 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.